- Home
- OCFC vs RCKT Comparison
OCFC vs RCKT Comparison
Compare OCFC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFC
- RCKT
- Stock Information
- Founded
- OCFC 1902
- RCKT 1999
- Country
- OCFC United States
- RCKT United States
- Employees
- OCFC N/A
- RCKT N/A
- Industry
- OCFC Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- OCFC Finance
- RCKT Health Care
- Exchange
- OCFC Nasdaq
- RCKT Nasdaq
- Market Cap
- OCFC 861.7M
- RCKT 764.5M
- IPO Year
- OCFC 1996
- RCKT N/A
- Fundamental
- Price
- OCFC $17.55
- RCKT $6.50
- Analyst Decision
- OCFC Buy
- RCKT Strong Buy
- Analyst Count
- OCFC 4
- RCKT 11
- Target Price
- OCFC $21.25
- RCKT $37.73
- AVG Volume (30 Days)
- OCFC 269.7K
- RCKT 3.2M
- Earning Date
- OCFC 04-24-2025
- RCKT 05-08-2025
- Dividend Yield
- OCFC 4.51%
- RCKT N/A
- EPS Growth
- OCFC N/A
- RCKT N/A
- EPS
- OCFC 1.53
- RCKT N/A
- Revenue
- OCFC $369,879,000.00
- RCKT N/A
- Revenue This Year
- OCFC $0.75
- RCKT N/A
- Revenue Next Year
- OCFC $12.16
- RCKT N/A
- P/E Ratio
- OCFC $11.59
- RCKT N/A
- Revenue Growth
- OCFC N/A
- RCKT N/A
- 52 Week Low
- OCFC $14.03
- RCKT $4.55
- 52 Week High
- OCFC $21.87
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- OCFC 61.06
- RCKT 45.55
- Support Level
- OCFC $17.16
- RCKT $5.72
- Resistance Level
- OCFC $17.99
- RCKT $7.14
- Average True Range (ATR)
- OCFC 0.41
- RCKT 0.70
- MACD
- OCFC 0.13
- RCKT -0.06
- Stochastic Oscillator
- OCFC 75.69
- RCKT 30.71
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.